Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) General Information

Description

Provider of botanical actives and in vitro diagnostic ingredients intended for pharmaceutical, diagnostic, and health product manufacturers. The company develops plant-derived active compounds and specialized reagents for diagnostic kits, offering controlled sourcing and standardized production to support consistent formulation and testing outcomes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Limoges
  • France
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Acquirer
Solabia
Corporate Office
  • Limoges
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions)‘s full profile, request access.

Request a free trial

Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions)‘s full profile, request access.

Request a free trial

Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) FAQs

  • Where is Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) headquartered?

    Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) is headquartered in Limoges, France.

  • What industry is Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) in?

    Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions)’s primary industry is Discovery Tools (Healthcare).

  • Is Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) a private or public company?

    Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) is a Private company.

  • What is Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions)’s current revenue?

    The current revenue for Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) is .

  • Who are Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions)’s investors?

    Seqens has invested in Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions).

  • When was Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) acquired?

    Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) was acquired on 05-Mar-2026.

  • Who acquired Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions)?

    Seqens (Botanical Actives and In Vitro Diagnostics (IVD) Divisions) was acquired by Solabia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process